Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.08 USD | +0.96% | -0.89% | -14.00% |
04-30 | Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer | CI |
03-08 | Akero Therapeutics Raises $367 Million From Share Offering | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- AKRO Stock
- Revisions Akero Therapeutics, Inc.